Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of “Hold” from Brokerages

Shares of Hims & Hers Health, Inc. (NYSE:HIMS) have earned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $20.71.

A number of equities research analysts have issued reports on HIMS shares. Piper Sandler reissued a “neutral” rating and set a $21.00 target price (up previously from $18.00) on shares of Hims & Hers Health in a research note on Tuesday, November 5th. Canaccord Genuity Group boosted their price target on shares of Hims & Hers Health from $24.00 to $28.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Imperial Capital lowered shares of Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research report on Friday, August 9th. Needham & Company LLC started coverage on shares of Hims & Hers Health in a report on Thursday, August 22nd. They issued a “buy” rating and a $24.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a research note on Wednesday, November 6th.

Hims & Hers Health Stock Down 7.4 %

Shares of NYSE HIMS opened at $21.80 on Thursday. The firm has a fifty day moving average of $20.21 and a 200-day moving average of $19.09. Hims & Hers Health has a 52-week low of $7.51 and a 52-week high of $30.44. The stock has a market capitalization of $4.76 billion, a PE ratio of 49.55 and a beta of 1.06.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings data on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.26. The firm had revenue of $401.56 million for the quarter, compared to analyst estimates of $382.20 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. Hims & Hers Health’s quarterly revenue was up 77.1% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.04) earnings per share. Equities research analysts expect that Hims & Hers Health will post 0.29 EPS for the current fiscal year.

Insider Buying and Selling

In other news, COO Melissa Baird sold 58,750 shares of Hims & Hers Health stock in a transaction on Monday, November 18th. The shares were sold at an average price of $21.04, for a total value of $1,236,100.00. Following the completion of the sale, the chief operating officer now owns 630,166 shares in the company, valued at $13,258,692.64. The trade was a 8.53 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Andrew Dudum sold 188,888 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $14.56, for a total transaction of $2,750,209.28. Following the sale, the chief executive officer now owns 33,502 shares of the company’s stock, valued at $487,789.12. This trade represents a 84.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,056,183 shares of company stock worth $21,501,682 in the last ninety days. Company insiders own 17.71% of the company’s stock.

Institutional Trading of Hims & Hers Health

Several institutional investors have recently made changes to their positions in HIMS. Nisa Investment Advisors LLC grew its stake in shares of Hims & Hers Health by 679.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock worth $37,000 after acquiring an additional 1,603 shares in the last quarter. Quest Partners LLC boosted its holdings in shares of Hims & Hers Health by 5,944.1% in the 2nd quarter. Quest Partners LLC now owns 3,566 shares of the company’s stock worth $72,000 after buying an additional 3,507 shares during the last quarter. CWM LLC boosted its holdings in shares of Hims & Hers Health by 21.4% in the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after buying an additional 1,054 shares during the last quarter. Van ECK Associates Corp purchased a new position in shares of Hims & Hers Health in the 2nd quarter worth about $111,000. Finally, Quarry LP boosted its holdings in shares of Hims & Hers Health by 91.0% in the 3rd quarter. Quarry LP now owns 6,113 shares of the company’s stock worth $113,000 after buying an additional 2,913 shares during the last quarter. Institutional investors own 63.52% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.